Concepedia

Aditya Parekh

AP

Statistics

Publications

14

Citations

738

H-Index

13

Active since

2010

Affiliations

Indian Institute of Technology Kharagpur(Current)

The University of Texas MD Anderson Cancer Center

Aditya Parekh is an author at Indian Institute of Technology Kharagpur specializing in oncology, life sciences, and cancer cell signaling.

ORCID

Publications per year

2010–2019

14

Publications

14

Molecular targeting of Akt by thymoquinone promotes G1 arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells

Shashi Rajput, B. N. Prashanth Kumar, Kaushik Dey et al. · Life Sciences · 2013 · 142 citations

, , +13

Lactate dehydrogenase A regulates autophagy and tamoxifen resistance in breast cancer

Chandan Kanta Das, Aditya Parekh, Pratap Parida et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 2019 · 126 citations

, , +16

Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo

Aditya Parekh, Subhayan Das, Sheetal Parida et al. · Oncogene · 2018 · 101 citations

, , +13

Gold nanorod embedded reduction responsive block copolymer micelle-triggered drug delivery combined with photothermal ablation for targeted cancer therapy

Sheetal Parida, Chiranjit Maiti, Y. Rajesh et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 2016 · 67 citations

, , +17

Celecoxib alleviates tamoxifen-instigated angiogenic effects by ROS-dependent VEGF/VEGFR2 autocrine signaling

B. N. Prashanth Kumar, Shashi Rajput, Kaushik Dey et al. · BMC Cancer · 2013 · 65 citations · Full text

, , +17

1–5 of 14